Device
ExAblate 2000
ExAblate 2000 is a medical device with 6 clinical trials. Historical success rate of 66.7%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 4 completed trials
Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Terminated
2(33%)
Phase Distribution
Ph not_applicable
3
50%
Ph phase_3
2
33%
Ph phase_1
1
17%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
3(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
4 of 6 finished
Non-Completion Rate
33.3%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(2)
Detailed Status
Completed4
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (16.7%)
Phase 32 (33.3%)
N/A3 (50.0%)
Trials by Status
completed467%
terminated233%
Recent Activity
0 active trials
Showing 5 of 6
completednot_applicable
Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids
NCT00131365
completedphase_3
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation
NCT00295217
terminatednot_applicable
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
NCT00730886
completednot_applicable
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
NCT00166270
terminatedphase_3
MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas
NCT00147108
Clinical Trials (6)
Showing 6 of 6 trials
NCT00131365Not Applicable
Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids
NCT00295217Phase 3
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation
NCT00730886Not Applicable
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
NCT00166270Not Applicable
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
NCT00147108Phase 3
MR Guided Focused Ultrasound Surgery in the Treatment of Breast Fibroadenomas
NCT00350233Phase 1
MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6